| Literature DB >> 24957369 |
Gözde Gürdeniz1, Mette Kristensen2, Thomas Skov3, Lars O Dragsted4.
Abstract
The metabolic composition of plasma is affected by time passed since the last meal and by individual variation in metabolite clearance rates. Rat plasma in fed and fasted states was analyzed with liquid chromatography quadrupole-time-of-flight mass spectrometry (LC-QTOF) for an untargeted investigation of these metabolite patterns. The dataset was used to investigate the effect of data preprocessing on biomarker selection using three different softwares, MarkerLynxTM, MZmine, XCMS along with a customized preprocessing method that performs binning of m/z channels followed by summation through retention time. Direct comparison of selected features representing the fed or fasted state showed large differences between the softwares. Many false positive markers were obtained from custom data preprocessing compared with dedicated softwares while MarkerLynxTM provided better coverage of markers. However, marker selection was more reliable with the gap filling (or peak finding) algorithms present in MZmine and XCMS. Further identification of the putative markers revealed that many of the differences between the markers selected were due to variations in features representing adducts or daughter ions of the same metabolites or of compounds from the same chemical subclasses, e.g., lyso-phosphatidylcholines (LPCs) and lyso-phosphatidylethanolamines (LPEs). We conclude that despite considerable differences in the performance of the preprocessing tools we could extract the same biological information by any of them. Carnitine, branched-chain amino acids, LPCs and LPEs were identified by all methods as markers of the fed state whereas acetylcarnitine was abundant during fasting in rats.Entities:
Year: 2012 PMID: 24957369 PMCID: PMC3901197 DOI: 10.3390/metabo2010077
Source DB: PubMed Journal: Metabolites ISSN: 2218-1989
Figure 1Venn diagrams illustrating the number of common and method specific features extracted from three software tools (right: positive mode; left: negative mode).
Figure 2PCA scores plots of negative mode data processed with MarkerLynx (a), MZmine (b), XCMS (c) and customized methods (d).
Retention times and measured masses of the markers obtained from MarkerLynx, MZmine, XCMS and custom data processing of negative mode data that contributed most to the separation of samples in fasted and fed states.
| NO | RT (min) | Measured
| MX Rank | MZ Rank | XCMS Rank | Custom rank | Group | Suggested Compound | Adduct | Monoisotopic mass |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 0.64 | 105.02 | 57 | 17 | 14 | 194 | fed | U1 | ||
| 2 | 0.82 | 116.07 | 91 | 26 | 17 | 507 | fed | U2 | ||
| 3 | 1.15 | 180.06 | 67 | 28 | 21 | 27 | fed | U3 | ||
| 4 | 1.15 | 383.12 | 40 | 80 | 25 | 624 | fed | U3 | ||
| 5 | 1.36 | 59.01 | 21 | 34 | 9 | 7 | fasted | 3-hydroxybutanoic acid F | 104.0473 | |
| 6 | 1.36 | 260.00 | 49 | 68 | nd | 22 | fasted | 3-hydroxybutanoic acid F | 104.0473 | |
| 7 | 1.37 | 229.07 | 20 | 35 | nd | 72 | fasted | 3-hydroxybutanoic acid A | [2M+Na-H] | 104.0473 |
| 8 | 1.37 | 103.04 | 39 | 15 | nd | 20 | fasted | 3-hydroxybutanoic acid | [M-H] | 104.0473 |
| 9 | 1.37 | 261.18 | 1424 | nd | 18 | 14 | fed | Isoleucine | [2M-H] | 131.0946 |
| 10 | 1.37 | 130.09 | 25 | nd | 24 | 65 | fed | Isoleucine | [M-H]- | 131.0946 |
| 11 | 1.80 | 178.05 | nd | 22 | nd | 166 | fed | U4 | ||
| 12 | 1.88 | 134.06 | 14 | 9 | 6 | 40 | fasted | Hippuric acid * F | 179.0582 | |
| 13 | 1.88 | 178.05 | 15 | 7 | 4 | 116 | fasted | Hippuric acid * | [M-H] | 179.0582 |
| 14 | 2.02 | 344.10 | 383 | nd | 222 | 12 | none | U5 | ||
| 15 | 2.46 | 365.07 | 3 | 6 | nd | 43 | fed | U6 | ||
| 16 | 2.46 | 623.36 | 8 | nd | 3 | 94 | fed | U6 | ||
| 17 | 2.46 | 343.08 | 2 | 2 | 1 | 6 | fed | U6 | ||
| 18 | 2.47 | 623.87 | 4 | nd | nd | 16 | fed | U7 | ||
| 19 | 3.00 | 185.12 | 793 | 23 | 77 | 284 | fed | U8 | ||
| 20 | 3.50 | 505.30 | 1833 | nd | nd | 10 | none | U9 | ||
| 21 | 4.11 | 586.31 | nd | 13 | nd | 13 | fed | LPC(20:5) | [M+FA-H] | 541.3168 |
| 22 | 4.12 | 309.20 | 1 | 10 | 7 | 1802 | fed | LPC(20:5) F | 541.3168 | |
| 23 | 4.15 | 452.28 | 22 | 30 | 22 | 1006 | fed | LPC(14:0) F | 467.3012 | |
| 24 | 4.16 | 512.30 | 17 | 21 | 19 | 45 | fed | LPC(14:0) A | [M+FA-H] | 467.3012 |
| 25 | 4.16 | 979.60 | 19 | nd | nd | 33 | fed | LPC(14:0) A | [2M+FA-H] | 467.3012 |
| 26 | 4.17 | 502.29 | 13 | 11 | nd | 25 | fed | LPC(18:3) F | 517.3168 | |
| 27 | 4.18 | 562.31 | 5 | 8 | 51 | 17 | fed | LPC(18:3) | [M+FA-H] | 517.3168 |
| 28 | 4.18 | 818.50 | 16 | nd | nd | 1672 | fed | U10 | ||
| 29 | 4.18 | 526.30 | 11 | 19 | 11 | 912 | fed | LPC(20:5) F | 541.3168 | |
| 30 | 4.19 | 586.31 | 7 | 18 | 8 | 13 | fed | LPC(20:5) | [M+FA-H] | 541.3168 |
| 31 | 4.23 | 563.32 | nd | nd | 13 | 15 | fed | U11 | ||
| 32 | 4.34 | 476.28 | 23 | 1 | nd | 1 | fed | 2-acyl LPC(18:2) F | 519.3325 | |
| 33 | 4.35 | 564.33 | 10 | 12 | nd | 3 | fed | 2-acyl LPC(18:2) | [M+FA-H] | 519.3325 |
| 34 | 4.35 | 504.31 | 147 | 3 | nd | 2 | fed | 2-acyl LPC(18:2) F | 519.3325 | |
| 35 | 4.35 | 578.30 | nd | 5 | nd | 35 | fasted | U12 | ||
| 36 | 4.36 | 632.33 | 120 | 25 | nd | 113 | fed | U13 | ||
| 37 | 4.38 | 281.25 | 33 | nd | 15 | nd | fasted | U14 | ||
| 38 | 4.43 | 476.28 | 105 | 4 | 2 | 1 | fed | 1-acyl LPC(18:2) F | 519.3325 | |
| 39 | 4.44 | 168.35 | 6 | nd | nd | 1512 | fed | 1-acyl LPC(18:2) F | 519.3325 | |
| 40 | 4.44 | 995.59 | 60 | nd | nd | 4 | fed | 1-acyl LPC(18:2) F | 519.3325 | |
| 41 | 4.44 | 168.63 | 18 | nd | nd | 170 | fed | 1-acyl LPC(18:2) F | 519.3325 | |
| 42 | 4.44 | 504.31 | 65 | 14 | 32 | 2 | fed | 1-acyl LPC(18:2) F | 519.3325 | |
| 43 | 4.45 | 457.10 | 12 | nd | 561 | 2332 | fasted | U15 | ||
| 44 | 4.45 | 564.33 | 32 | 31 | 20 | 3 | fed | 1-acyl LPC(18:2) | [M+FA-H] | 519.3325 |
| 45 | 4.45 | 335.40 | nd | nd | nd | 8 | none | none | ||
| 46 | 4.45 | 335.70 | nd | nd | nd | 9 | none | none | ||
| 47 | 4.45 | 477.28 | nd | nd | nd | 21 | fed | 1-acyl LPC(18:2) iso1 | ||
| 48 | 4.45 | 564.10 | nd | nd | nd | 23 | none | none | ||
| 49 | 4.45 | 565.34 | nd | nd | nd | 5 | fed | 1-acyl LPC(18:2) iso2 | ||
| 50 | 4.45 | 587.30 | nd | nd | nd | 11 | none | none | ||
| 51 | 4.45 | 996.59 | nd | nd | nd | 19 | fed | 1-acyl LPC(18:2) iso3 | ||
| 52 | 4.50 | 552.33 | 24 | 46 | 63 | 320 | fed | U16 | ||
| 53 | 4.62 | 452.28 | 48 | 55 | 23 | 1006 | fasted | U17 | ||
| 54 | 4.65 | 566.35 | 374 | 24 | nd | 138 | fed | 1-acyl LPC(18:1) | [M+FA-H] | 521.3481 |
| 55 | 4.73 | 478.29 | 9 | 16 | 12 | 18 | fed | LPE(18:1) * | [M-H] | 479.3012 |
| 56 | 4.88 | 445.33 | 76 | 20 | 10 | 1206 | fasted | U19 | ||
| 57 | 5.14 | 277.22 | 85 | 106 | 5 | 98 | fasted | Gamma-Linolenic acid * | [M-H] | 278.2246 |
| 58 | 5.22 | 338.30 | 100 | nd | nd | 24 | none | U20 | ||
| 59 | 5.38 | 279.23 | 145 | nd | 16 | 177 | fasted | Linoleic acid * | [M-H] | 280.2402 |
MX: MarkerLynx; MZ: MZmine; ‘U’, Unidentified compound; A: Adduct; F: Fragment *, identity confirmed with authentic standards; ‘nd’, not detected by the software peak-finding algorithm.
Retention times and measured masses of the markers obtained from MarkerLynx, MZmine, XCMS and custom data processing of positive mode data that contributed most to the separation of samples in fasted and fed states.
| NO | RT (min) | Measured
| MX Rank | MZ Rank | XCMS Rank | Custom rank | Group | SuggestedCompound | Suggested Adduct | Monoisotopic mass |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 0.53 | 112.11 | nd | 12 | 13 | 301 | fasted | U1 | ||
| 2 | 0.57 | 730.70 | 276 | nd | nd | 25 | fasted | U2 | ||
| 3 | 0.61 | 103.04 | 46 | nd | 19 | 2901 | fed | L-Carnitine *F | 161.1052 | |
| 4 | 0.61 | 102.09 | 1368 | nd | 21 | 481 | fed | L-Carnitine *F | 161.1052 | |
| 5 | 0.61 | 162.11 | 31 | 41 | 10 | 10 | fed | L-Carnitine * | [M+H] | 161.1052 |
| 6 | 0.66 | 70.07 | 12 | 11 | 25 | 22 | fed | D-proline *F | 115.0633 | |
| 7 | 0.66 | 116.07 | 13 | 14 | 12 | 11 | fed | D-proline * | [M+H] | 115.0633 |
| 8 | 0.86 | 130.09 | 24 | 521 | 44 | 838 | fasted | U3 | ||
| 9 | 0.90 | 144.10 | 23 | nd | 16 | 455 | fasted | L-Acetylcarnitine*F | 203.1158 | |
| 10 | 0.90 | 204.12 | 28 | 18 | 6 | 8 | fasted | L-Acetylcarnitine* | [M+H] | 203.1158 |
| 11 | 0.90 | 145.05 | 21 | 13 | 11 | 41 | fasted | L-Acetylcarnitine*F | 203.1158 | |
| 12 | 1.17 | 248.15 | 49 | 23 | 7 | 38 | fasted | U4 | ||
| 13 | 1.64 | 231.12 | nd | 100 | 1 | 649 | fasted | U5 | ||
| 14 | 1.90 | 105.03 | 1 | 17 | 2 | 78 | fasted | Hippuric Acid*F | 179.0582 | |
| 15 | 1.90 | 77.04 | 3 | 19 | 3 | 578 | fasted | Hippuric Acid*F | 179.0582 | |
| 16 | 2.23 | 316.21 | 19 | 46 | nd | 179 | fasted | U6 | ||
| 17 | 2.42 | 899.43 | nd | nd | nd | 17 | fed | U7 | ||
| 18 | 2.42 | 287.20 | nd | nd | nd | 1 | fed | U7 | ||
| 19 | 2.42 | 286.20 | 7 | 3 | 50 | 4 | fed | U7 | ||
| 20 | 3.42 | 536.34 | 35 | nd | nd | 24 | fed | U8 | ||
| 21 | 3.49 | 158.16 | 338 | 222 | 63 | 19 | fasted | U9 | ||
| 22 | 4.11 | 542.33 | 16 | 16 | nd | 21 | fed | LPC(20:5) | [M+H] | 541.3168 |
| 23 | 4.12 | 564.31 | nd | 15 | nd | 43 | fed | LPC(20:5) A | [M+Na] | 541.3168 |
| 24 | 4.16 | 312.03 | 151 | nd | 17 | 2659 | fed | U10 | ||
| 25 | 4.16 | 468.31 | 20 | 24 | 23 | 15 | fed | LPC(14:0) | [M+H] | 467.3012 |
| 26 | 4.19 | 540.31 | 25 | 64 | nd | 47 | fed | LPC(18:3) A | [M+Na] | 517.3168 |
| 27 | 4.19 | 518.33 | 15 | 6 | 81 | 62 | fed | LPC(18:3) | [M+H] | 517.3168 |
| 28 | 4.23 | 445.40 | nd | nd | nd | 12 | fasted | octadecanoylcarnitineIso | ||
| 29 | 4.23 | 444.37 | 18 | 33 | 47 | 33 | fasted | octadecanoylcarnitine | ||
| 30 | 4.35 | 337.28 | 9 | 9 | 5 | 57 | fed | 2-acyl LPC(18:2) F | 519.3325 | |
| 31 | 4.35 | 520.34 | 6 | 1 | nd | 2 | fed | 2-acyl LPC(18:2) | [M+H] | 519.3325 |
| 32 | 4.36 | 542.33 | 4 | 2 | nd | 21 | fed | 2-acyl LPC (18:2) A | [M+Na] | 519.3325 |
| 33 | 4.36 | 819.96 | 22 | nd | nd | 950 | fed | U11 | ||
| 34 | 4.36 | 502.33 | nd | 10 | nd | 28 | fed | 2-acyl LPC(18:2) F | [M+Na] | 479.3376 |
| 35 | 4.42 | 566.32 | 1024 | 2058 | 15 | 50 | fasted | U12 | ||
| 36 | 4.42 | 844.47 | 219 | 233 | 20 | 1312 | fasted | U13 | ||
| 37 | 4.44 | 519.90 | nd | nd | nd | 18 | fed | U14 | ||
| 38 | 4.44 | 521.35 | nd | nd | nd | 5 | fed | 1-acyl LPC(18:2) Iso1 | [M+H] | 519.3325 |
| 39 | 4.45 | 523.35 | nd | 7 | nd | 89 | fed | 1-acyl LPC(18:2)Iso2 | [M+H] | 519.3325 |
| 40 | 4.45 | 519.70 | 316 | nd | nd | 7 | fed | U15 | ||
| 41 | 4.45 | 997.64 | 14 | 20 | 9 | 3 | fed | 1-acyl LPC(18:2) A | 519.3325 | |
| 42 | 4.45 | 819.97 | 2 | 21 | 835 | 950 | fasted | U16 | ||
| 43 | 4.45 | 520.34 | 8 | 4 | 18 | 2 | fed | 1-acyl LPC(18:2) | [M+H] | 519.3325 |
| 44 | 4.45 | 998.64 | 30 | nd | nd | 6 | fed | U17 | ||
| 45 | 4.45 | 460.29 | 59 | 54 | 14 | 612 | fed | 1-acyl LPC(18:2) F | 519.3325 | |
| 46 | 4.45 | 520.10 | nd | nd | nd | 13 | none | U18 | ||
| 47 | 4.45 | 520.90 | nd | nd | nd | 23 | none | U18 | ||
| 48 | 4.45 | 521.55 | nd | nd | nd | 20 | none | U18 | ||
| 49 | 4.45 | 521.80 | nd | nd | nd | 16 | none | U18 | ||
| 50 | 4.45 | 807.97 | 5 | 8 | 4 | 2664 | fed | U19 | ||
| 51 | 4.63 | 949.64 | 34 | 25 | 48 | 85 | fasted | U20 | ||
| 52 | 4.64 | 454.30 | 32 | 22 | 22 | 1425 | fasted | U20 | ||
| 53 | 4.65 | 975.70 | 76 | nd | nd | 14 | fed | U21 | ||
| 54 | 4.65 | 522.36 | 10 | nd | nd | 70 | fed | 2-acyl LPC(18:1) * | [M+H] | 521.3481 |
| 55 | 4.65 | 339.29 | 17 | 5 | 8 | 573 | fed | 2-acyl LPC(18:1) *F | ||
| 56 | 4.68 | 520.34 | 11 | nd | 24 | 2 | fed | U22 | [M+H] | 519.3325 |
MX: MarkerLynx; MZ: MZmine; ‘U’, Unidentified compound; A: Adduct; F: Fragment *, identity confirmed with authentic standards; ‘nd’, not detected by the software peak-finding algorithm.
Figure 3(a) Pie chart illustrating the number of custom data preprocessing markers that are unique and that are detected as markers by the other software tools (CS:Custom, MZ:MZmine, XC:XCMS, MX:Markerlynx); (b) Venn diagrams illustrating the number of common and method specific markers extracted from three software tools (right: positive mode; left: negative mode).
Figure 4Heatmap comparing the importance of each marker based on four different data preprocessing tools for (a) negative and (b) positive mode data. Each row represents the lowest value rank of a metabolite for four different methods (Table 1, 3rd column). The markers were sorted in ascending order based on the rank obtained with MarkerLynx (red: rank 1–25; orange: rank 26–50; yellow: rank > 50; black: not detected).
Figure 5Custom data preprocessing scheme.